Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • January News and Product Briefs

    Jan 29, 2016, 10:20 AM by Michael Croft
    Bio-IT World | The latest products and announcements from around the industry, including a high-throughput protein conformation analyzer, and updates to the cloud-based genome analysis services of both DNAnexus and Seven Bridges.
    Full story
  • FACILITY EXPANSION AT CRO FOLLOWING RECORD YEAR

    Jan 29, 2016, 06:48 AM by Michael Croft
    SUNDERLAND, UNITED KINGDOM - Jan 29, 2016 - ONYX Scientific is set to increase the size of its UK-based site by over 30pc following the best performance in the company’s 15 year history
    Full story
  • 'Remarkable Turning Point' as Medical Journals Require Clinical Trial Data Sharing

    Jan 28, 2016, 10:19 AM by Michael Croft
    STAT | Harlan Krumholz, of the Yale Open Data Access project, speaks about a new proposal by the International Committee of Medical Journal Editors.
    Full story
  • ONO PHARMACEUTICAL Selects Medidata to Power Clinical Trials Exploring Additional Cancer Indications for Immunotherapy Drug OPDIVO® (nivolumab)

    Jan 28, 2016, 09:56 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Jan 26, 2016 -  Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, announced today that ONO PHARMACEUTICAL CO
    Full story
  • Scientists Move Closer to Understanding Schizophrenia’s Cause

    Jan 27, 2016, 15:03 PM by Michael Croft
    New York Times | A massive genomic study provides researchers with a strong case for a biological mechanism involved in the disorder, and helps explain why it often begins at a relatively young age.
    Full story
  • Ferring Pharmaceuticals to Fund Research Center for Microbiome-Based Therapies

    Jan 27, 2016, 11:40 AM by Michael Croft
    Bio-IT World News Brief | Swiss drugs company Ferring Pharmaceuticals will fully fund the creation of a joint research center with the Karolinska Institutet of Sweden, to conduct human microbiome studies with an eye on new therapies.
    Full story
  • Illumina Buys Conexio for HLA Typing Business

    Jan 26, 2016, 15:45 PM by Michael Croft
    Bio-IT World News Brief | Illumina has purchased Conexio Genomics, an Australian company that was one of the first to develop products for using next-generation sequencing in matching tissue donors and recipients through HLA genotyping.
    Full story
  • The Forest in Your Mouth

    Jan 25, 2016, 16:14 PM by Michael Croft
    Phenomena | A study using many parallel probes has revealed the spatial organization of different bacterial species in dental plaque. The strategy could be used to explore microbial ecology in all sorts of environments.
    Full story
  • How the World's Governments Have Regulated Human Genome Editing

    Jan 25, 2016, 13:50 PM by Michael Croft
    Bio-IT World | Members of McGill University’s Centre of Genomics and Policy have published a global survey of restrictions on modifying the human genome, concluding that many regulations are vague and that bans or limitations often relax over time.
    Full story
  • Data Scientists = Research Parasites?

    Jan 22, 2016, 10:57 AM by Michael Croft
    Forbes | David Shaywitz weighs in on yesterday's editorial from NEJM calling data scientists "research parasites." He was glad, he says, for a major objection to finally be laid out. Now we can move past it.
    Full story
  • Adaptive Computing Achieves Record High Throughput on Supermicro Solutions

    Jan 21, 2016, 18:04 PM by Michael Croft
    PROVO, UT, US - Jan 22, 2016 - Adaptive Computing, provider of award-winning workload and resource orchestration software, announces it has set a new record in High Throughput Computing (HTC) in collaboration with Supermicro, a leader in high-performance green computing solutions
    Full story
  • Why Data Scientist Is This Year's Hottest Job

    Jan 21, 2016, 15:35 PM by Michael Croft
    Computerworld | It's notable enough that close to half of the 25 "best jobs in America" named by recruiting site Glassdoor this week are tech-related, but even more striking is the fact that "data scientist" tops the list.
    Full story
  • Biodesy Launches Only Real-Time, High-Throughput System for Measuring Protein Conformational Change

    Jan 21, 2016, 15:15 PM by Michael Croft
    SOUTH SAN FRANCISCO, CA - Jan 21, 2016 - Biodesy, Inc., a next-generation protein analysis company, today announced the global availability of its Biodesy™ Delta System for measuring conformational change
    Full story
  • Biodesy Completes $10 Million Series B Financing to Accelerate Commercialization of Next-Generation Protein Analysis Technology

    Jan 21, 2016, 15:12 PM by Michael Croft
    SOUTH SAN FRANCISCO, CA - Jan 21, 2016 - Biodesy, Inc., a next-generation protein analysis company, today announced the closing of its $10 million Series B financing and its 20th commercial services agreement using its proprietary, first-in-class technology for measuring protein conformational change
    Full story
  • Pharma Industry Calls on Governments to Fund New Antibiotics

    Jan 21, 2016, 11:11 AM by Michael Croft
    Phenomena | At the World Economic Forum in Davos, a group of almost 100 pharma companies and trade associations have released a bare bones outline of a plan to spur research into new antibiotics and encourage their responsible use.
    Full story
  • Can Big Genomic Data Reveal the Fundamental Units of the Brain?

    Jan 20, 2016, 11:10 AM by Michael Croft
    Bio-IT World | An ambitious new study from the Allen Institute for Brain Science illustrates how new methods for isolating and studying single cells, combined with massive RNA sequencing data, are changing the way neuroscientists think about the variety and organization of cells in the brain.
    Full story
  • CSM Announces Two Key Executive Promotions

    Jan 19, 2016, 10:37 AM by Michael Croft
    FARGO, ND - Jan 20, 2016 - CSM, a leading clinical trial supply company, today announced that Brian Swites was promoted to Vice President of Operations and Bob Albanese was named Senior Vice President of Strategic Development
    Full story
  • AAAS Selects Danforth Center Principal Investigator to Serve as Chair-Elect for the Biological Sciences

    Jan 19, 2016, 09:59 AM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Jan 19, 2016 - The Donald Danforth Plant Science Center announced Elizabeth (Toby) Kellogg , Ph.D., member and principal investigator was selected by the American Association for the Advancement of Science  (AAAS) to serve as chair-elect for the Biological Sciences Section beginning in late February this year
    Full story
  • Aridhia’s data platform used in major £64m European research collaboration to tackle Alzheimer’s dementia

    Jan 19, 2016, 05:43 AM by Michael Croft
    EDINBURGH, UNITED KINGDOM - Jan 19, 2016 - Aridhia has today announced that it is among 36 organisations behind a ground-breaking Innovative Medicines Initiative research programme that aims to build a platform for efficient testing of innovative treatments for the prevention of Alzheimer’s dementia
    Full story
  • The Muscular Dystrophy Patient and Olympic Medalist with the Same Genetic Disorder

    Jan 18, 2016, 11:08 AM by Michael Croft
    ProPublica | David Epstein tells the story of how a woman whose muscles disappeared discovered, through years of dogged research, that she shared a disease with a muscle-bound Olympic athlete.
    Full story
  • «
  • 351
  • 352 (current)
  • 353
  • 354
  • 355
  • 356
  • 357
  • 358
  • 359
  • 360
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy